Quantcast

Latest Endo Pharmaceuticals Stories

2014-09-08 08:29:47

First and only generic 2% topical testosterone gel DUBLIN, Sept. 8, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that it has introduced the first and only generic 2% topical testosterone gel, an authorized generic of FORTESTA® Gel (testosterone gel) CIII. FORTESTA Gel and its Authorized Generic version are the first and only 2% testosterone gels approved by the U.S. Food and Drug Administration to treat adult males diagnosed with hypogonadism. The...

2014-08-04 16:26:29

NEWARK, Calif., Aug. 4, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of R. Scott Shively, as Chief Commercial Officer and Senior Vice President. Mr. Shively has extensive commercial leadership experience in sales and marketing of pain and neurology products, for both specialty as well as larger pharmaceutical companies. Mr. Shively served as Executive Vice President and Chief Commercial Officer of Zogenix from November 2012 through August...

2014-06-02 08:29:30

DUBLIN, June 2, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that its Endo Pharmaceuticals subsidiary has completed the sale of its branded pharmaceutical drug discovery platform to AsanaBioSciences, LLC, an independent member of the Amneal Alliance of Companies. The deal includes an upfront payment as well as milestones on the achievement of certain development objectives. Endo initiated the exploration of strategic alternatives for the...

2014-05-08 20:24:26

BUNAVAIL PDUFA date June 7, 2014; Pre-launch activities underway to support an anticipated late Q3 2014 launch RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's recent achievements and an update on business operations and upcoming...

2014-04-23 08:30:49

TAIPEI, April 23, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related to TWi's lidocaine topical patch 5% product. An Abbreviated New Drug Application (ANDA) for TWi's product is currently under review at the U.S. Food and Drug Administration (FDA). If approved, TWi's product would be a...

2014-04-11 08:24:31

PITTSBURGH, April 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Frovatriptan Succinate Tablets, 2.5 mg. This product is the generic version of FROVA(®), which is used to treat acute...

2014-04-09 23:27:26

Campaign with Endo Pharmaceuticals and HealthyWomen Encourages Osteoarthritis Joint Pain Sufferers to ‘Get Up and Get Active’ DUBLIN (PRWEB) April 09, 2014 Emmy-nominated choreographer, nine-time Dancing with the Stars professional and creator of LaBlast dance fitness program Louis Van Amstel is not typically associated with painful joints. But now he is working with HealthyWomen and Endo Pharmaceuticals, a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), to help raise...

2014-04-09 08:28:23

Campaign with Endo Pharmaceuticals and HealthyWomen Encourages Osteoarthritis Joint Pain Sufferers to 'Get Up and Get Active' DUBLIN, April 9, 2014 /PRNewswire/ -- Emmy-nominated choreographer, nine-time Dancing with the Stars professional and creator of LaBlast dance fitness program Louis Van Amstel is not typically associated with painful joints. But now he is working with HealthyWomen and Endo Pharmaceuticals, a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), to help raise...

2014-04-09 08:26:56

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 9, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Laboratory Corp. of America Holdings (NYSE: LH), Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), Cognizant Technology Solutions Corporation (NASDAQ: CTSH), YY Inc. (NASDAQ: YY), and Yandex N.V. (NASDAQ: YNDX). Private wealth members receive these notes ahead of publication. To reserve...

2014-03-14 08:26:42

BUNAVAIL PDUFA date June 7, 2014; Plans underway for potential Q3 2014 launch RALEIGH, N.C., March 14, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's 2013 financials and achievements as well as an update on business operations and upcoming milestones for...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related